News – Page 140 – Endpoints News

Ipsen and Genfit secure FDA thumbs up for rare liver disease asset

11 months ago

FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay

11 months ago

Paxlovid did not beat placebo in Stanford-led long Covid study

11 months ago

GSK stands by Orange Book patents that FTC has asked to rescind

11 months ago

Kyowa Kirin invests $530M in first manufacturing site in North America

11 months ago

FDA establishes new meeting type to advise on drug safety technology

11 months ago

Teladoc names insurance executive as new CEO

11 months ago

EU launches two advice pilots for clinical trial applications as part of R&D push

11 months ago

Oculis touts Phase 2 results in dry eye disease, but most data aren't statistically significant

11 months ago

Skye's stock sinks following eye disease failure as company shifts focus to obesity

11 months ago

Shionogi inks deal for preclinical hearing loss therapies; Alvotech’s refinancing pact

11 months ago

Alumis files for IPO ahead of Phase 3 studies for second-gen TYK2 inhibitor

11 months ago

GSK nixes SpringWorks licensing deal focused on Blenrep-Ogsiveo for blood cancer

11 months ago

Moderna’s Covid and flu combo vaccine succeeds in Phase 3 study

11 months ago

GSK wins expanded FDA approval for RSV shot in at-risk adults ages 50 to 59

11 months ago

UK medtech raises $100M for two-in-one urinary incontinence treatment

11 months ago

FDA raises questions about Lilly's Alzheimer's drug; Adcomm votes against MDMA therapy; Inside Walmart Health's ...

11 months ago

Federal judge dismisses antitrust claims brought against Bristol Myers by insurers

11 months ago

FDA greenlights Geron’s imetelstat to treat anemia in certain cancer patients

11 months ago

Italian antitrust agency investigates Novartis, Biogen and others over Lucentis biosimilar

11 months ago

AbbVie and Alphabet's Calico added to Operation Warp Speed for rare diseases

11 months ago

Neuroscience company Rapport Therapeutics lists on Nasdaq

11 months ago

Aligos, Arbutus and others tout early hepatitis efficacy data at #EASL24

11 months ago

Ipsen returns to Marengo Therapeutics for new trispecific deal

11 months ago

First page Previous page 137 138 139140141 142 143 Next page Last page